Select Medical Holdings Co. (SEM) Receives $19.60 Consensus Price Target from Analysts

Shares of Select Medical Holdings Co. (NYSE:SEM) have been assigned an average rating of “Hold” from the ten research firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and four have given a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $19.60.

A number of equities analysts have commented on SEM shares. Royal Bank of Canada reaffirmed a “buy” rating and set a $19.00 price objective on shares of Select Medical in a research report on Wednesday, September 13th. ValuEngine raised shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Deutsche Bank reaffirmed a “buy” rating and set a $22.00 price objective on shares of Select Medical in a research report on Monday, November 6th. Robert W. Baird set a $25.00 price objective on shares of Select Medical and gave the stock a “buy” rating in a research report on Monday, October 23rd. Finally, Zacks Investment Research cut shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Tuesday, October 10th.

Select Medical (NYSE:SEM) traded down $0.10 during mid-day trading on Thursday, reaching $16.65. 2,240,641 shares of the company’s stock were exchanged, compared to its average volume of 682,387. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.51 and a current ratio of 1.51. Select Medical has a 1 year low of $12.00 and a 1 year high of $19.77. The company has a market capitalization of $2,238.22, a PE ratio of 21.17, a price-to-earnings-growth ratio of 1.31 and a beta of 1.35.

Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, November 2nd. The health services provider reported $0.14 EPS for the quarter, missing the Zacks’ consensus estimate of $0.16 by ($0.02). Select Medical had a return on equity of 11.44% and a net margin of 2.21%. The company had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same period last year, the firm earned $0.06 earnings per share. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. research analysts expect that Select Medical will post 0.85 EPS for the current fiscal year.

In other news, insider Scott A. Romberger sold 5,000 shares of the business’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $17.97, for a total value of $89,850.00. Following the completion of the sale, the insider now owns 168,211 shares of the company’s stock, valued at $3,022,751.67. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Michael E. Tarvin sold 18,500 shares of the business’s stock in a transaction dated Monday, October 30th. The shares were sold at an average price of $18.97, for a total transaction of $350,945.00. Following the completion of the sale, the insider now directly owns 340,044 shares of the company’s stock, valued at approximately $6,450,634.68. The disclosure for this sale can be found here. In the last three months, insiders sold 180,103 shares of company stock valued at $3,112,442. 19.93% of the stock is currently owned by company insiders.

Several institutional investors have recently made changes to their positions in the company. Pacad Investment Ltd. raised its stake in Select Medical by 58.7% in the second quarter. Pacad Investment Ltd. now owns 7,300 shares of the health services provider’s stock valued at $112,000 after purchasing an additional 2,700 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in Select Medical by 4.8% in the second quarter. PNC Financial Services Group Inc. now owns 8,709 shares of the health services provider’s stock valued at $133,000 after purchasing an additional 396 shares in the last quarter. Riverhead Capital Management LLC raised its stake in Select Medical by 78.0% in the second quarter. Riverhead Capital Management LLC now owns 8,722 shares of the health services provider’s stock valued at $134,000 after purchasing an additional 3,822 shares in the last quarter. Flinton Capital Management LLC raised its stake in Select Medical by 75.8% in the second quarter. Flinton Capital Management LLC now owns 9,744 shares of the health services provider’s stock valued at $150,000 after purchasing an additional 4,200 shares in the last quarter. Finally, Eqis Capital Management Inc. acquired a new position in Select Medical in the third quarter valued at about $201,000. 77.93% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “Select Medical Holdings Co. (SEM) Receives $19.60 Consensus Price Target from Analysts” was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://sportsperspectives.com/2017/12/17/select-medical-holdings-co-sem-receives-19-60-consensus-price-target-from-analysts.html.

Select Medical Company Profile

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply